Llama-derived phage display antibody arrays for FSHD
用于 FSHD 的源自美洲驼的噬菌体展示抗体阵列
基本信息
- 批准号:6438421
- 负责人:
- 金额:$ 12.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-30 至 2004-08-31
- 项目状态:已结题
- 来源:
- 关键词:Ungulate antibody bacterial virus complementary DNA genetic library genetically modified animals histopathology human subject immunofluorescence technique laboratory mouse microarray technology muscle proteins muscular dystrophy pathologic process patient oriented research technology /technique development western blottings
项目摘要
DESCRIPTION (provided by applicant): The aim of this project is to gain insight
in the cellular and molecular processes leading to dysfunction of the
neuromuscular system in FSHD patients by large scale analysis of protein
homeostasis in tissues and cell lines of patients and controls.
In the past few years, projects have been launched to study deregulation of
biological pathways in FSHD on RNA level. These strategies include differential
display and RNA profiling experiments on commercial and custom made DNA chips
and arrays. Despite their limitations, DNA arrays are now one of the most
commonly used and successful methods to determine the molecular and cellular
aspects of many acquired and genetic diseases. It is anticipated that also for
FSHD, this approach will provide a valuable contribution in understanding its
pathology. Nevertheless, protein levels, including the level of modified
proteins and the composition of protein complexes are of an order of importance
larger to understand FSHD pathophysiology. Consequently there is a need for
protein arrays.
The llama antibody technology provides a unique opportunity to develop protein
arrays. The power of the llama system for this purpose is that this animal
makes single (heavy) chain antibodies. Using the genetic information for this
single-chain repertoire for the construction of phage-display antibody
libraries abolishes the need to combine heavy- and light-chains, one of the
major drawbacks of conventional phage-display libraries. Moreover, these
single-chain antibodies tend to have a very high affinity and stability. It has
already been demonstrated that large naive and directed libraries of antibodies
can be generated. Experience in cloning, production and isolation of these
llama antibodies is available.
We propose to generate muscle-specific antibody arrays derived from Llama
single-chain phage-display clones. To this end, a Llama will be immunized with
human muscle protein homogenates, and after peak response, a phage display
library will be constructed. Antibody clones will be selected with a variety of
selection procedures (e.g. with recombinant proteins or with muscle homogenates
from different species) and arrayed on glass slides. Well characterized single
chain antibody arrays will be used to study FSHD pathophysiology on
fluorescently labeled protein homogenates of tissues and cell cultures of
patients and controls. Evidently, these antibodies can also be used
individually for specific immunohistochemical and immunocytochemical studies.
描述(申请人提供):本项目的目的是获得洞察力
在细胞和分子过程中导致细胞功能障碍
FSHD患者神经肌肉系统蛋白质的大规模分析
患者和对照组组织和细胞系的动态平衡。
在过去的几年里,已经启动了一些项目,研究放松对
FSHD在RNA水平上的生物学途径。这些策略包括差异化
商业和定制DNA芯片上的展示和RNA图谱实验
和数组。尽管存在局限性,DNA阵列现在是最多的
常用和成功的测定分子和细胞的方法
许多获得性和遗传性疾病的某些方面。预计也将用于
FSHD,这种方法将为理解其
病理学。然而,蛋白质水平,包括修饰的水平
蛋白质和蛋白质复合体的组成具有重要的顺序
了解FSHD的病理生理学。因此,有必要
蛋白质阵列。
骆驼抗体技术为开发蛋白质提供了一个独特的机会
数组。骆驼系统为此目的的力量是,这种动物
制造单(重)链抗体。利用遗传信息实现这一点
构建噬菌体展示抗体的单链抗体库
图书馆不再需要将重链和轻链结合在一起,这是
传统噬菌体展示文库的主要缺点。此外,这些
单链抗体往往具有非常高的亲和力和稳定性。它有
已经证明,大量幼稚和定向的抗体库
可以生成。在克隆、生产和分离这些病毒方面的经验
骆驼抗体是可用的。
我们建议从骆驼中产生肌肉特异性抗体阵列
单链噬菌体展示克隆。为此,骆驼将用
人肌肉蛋白匀浆,峰值反应后,噬菌体展示
图书馆将建成。抗体克隆将用各种不同的
选择程序(例如,使用重组蛋白或肌肉匀浆
来自不同物种),并排列在玻璃幻灯片上。很好地描述了单一
链状抗体阵列将用于研究FSHD的病理生理学
组织和细胞培养的荧光标记蛋白匀浆
病人和对照组。显然,这些抗体也可以用来
单独用于特定的免疫组织化学和免疫细胞化学研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SILVERE M VAN DER MAAREL其他文献
SILVERE M VAN DER MAAREL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SILVERE M VAN DER MAAREL', 18)}}的其他基金
Clonal isogenic and immortalized FSHD myoblasts with or without D4Z4 contraction
有或没有 D4Z4 收缩的克隆同基因永生化 FSHD 成肌细胞
- 批准号:
7978984 - 财政年份:2010
- 资助金额:
$ 12.5万 - 项目类别:
Identification of the gene defect underlying ICF2 syndrome
鉴定 ICF2 综合征背后的基因缺陷
- 批准号:
8080912 - 财政年份:2010
- 资助金额:
$ 12.5万 - 项目类别:
Clonal Isogenic and Immortalized FSHD Myoblasts with or without D4Z4 Contraction
有或没有 D4Z4 收缩的克隆同基因和永生化 FSHD 成肌细胞
- 批准号:
8138560 - 财政年份:2010
- 资助金额:
$ 12.5万 - 项目类别:
Identification of the gene defect underlying ICF2 syndrome
鉴定 ICF2 综合征背后的基因缺陷
- 批准号:
7953512 - 财政年份:2010
- 资助金额:
$ 12.5万 - 项目类别:
FSHD as a Disorder of Impaired RNA Biogenesis
FSHD 是一种 RNA 生物发生受损的疾病
- 批准号:
7493530 - 财政年份:2007
- 资助金额:
$ 12.5万 - 项目类别:
FSHD as a Disorder of Impaired RNA Biogenesis
FSHD 是一种 RNA 生物发生受损的疾病
- 批准号:
7290235 - 财政年份:2007
- 资助金额:
$ 12.5万 - 项目类别:
Llama-derived phage display antibody arrays for FSHD
用于 FSHD 的源自美洲驼的噬菌体展示抗体阵列
- 批准号:
6665019 - 财政年份:2001
- 资助金额:
$ 12.5万 - 项目类别:
Llama-derived phage display antibody arrays for FSHD
用于 FSHD 的源自美洲驼的噬菌体展示抗体阵列
- 批准号:
6534543 - 财政年份:2001
- 资助金额:
$ 12.5万 - 项目类别:
Project 1: Pathways and mechanisms repressing D4Z4 repeats
项目 1:抑制 D4Z4 重复序列的途径和机制
- 批准号:
9767871 - 财政年份:
- 资助金额:
$ 12.5万 - 项目类别:
相似海外基金
Development of B cell functional studies on primary antibody deficiencies
一抗缺陷 B 细胞功能研究的进展
- 批准号:
502607 - 财政年份:2024
- 资助金额:
$ 12.5万 - 项目类别:
Thymus antibody-secreting cells: major players in autoimmunity.
胸腺抗体分泌细胞:自身免疫的主要参与者。
- 批准号:
502578 - 财政年份:2024
- 资助金额:
$ 12.5万 - 项目类别:
ICF: AbVax Combination vaccination and broadly neutralising antibody therapy in HIV to induce a protective Tcell vaccinal effect, a mechanistic study
ICF:AbVax 联合疫苗接种和广泛中和 HIV 抗体疗法诱导保护性 T 细胞疫苗效应,一项机制研究
- 批准号:
MR/Y008847/1 - 财政年份:2024
- 资助金额:
$ 12.5万 - 项目类别:
Research Grant
Enabling The Targeted Delivery Of DNA G-quadruplex Ligands using a Novel Antibody DAR-1 Platform
使用新型抗体 DAR-1 平台实现 DNA G 四链体配体的靶向递送
- 批准号:
BB/Y002180/1 - 财政年份:2024
- 资助金额:
$ 12.5万 - 项目类别:
Research Grant
Antibody-Palladium Conjugates for Bioorthogonal Anti-Cancer Prodrug Activation
用于生物正交抗癌前药激活的抗体-钯缀合物
- 批准号:
EP/Y024540/1 - 财政年份:2024
- 资助金额:
$ 12.5万 - 项目类别:
Fellowship
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 12.5万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A Semi-Automated Antibody-Discovery Platform to Target Challenging Biomolecules
针对具有挑战性的生物分子的半自动化抗体发现平台
- 批准号:
MR/Y003616/1 - 财政年份:2024
- 资助金额:
$ 12.5万 - 项目类别:
Fellowship
Monitoring antibody protection against SARS-CoV-2 variants
监测抗体对 SARS-CoV-2 变体的保护作用
- 批准号:
MR/Y033698/1 - 财政年份:2024
- 资助金额:
$ 12.5万 - 项目类别:
Research Grant
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
- 批准号:
479128 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
Operating Grants
Pharmacokinetic analysis of antibody drug conjugate in tumor cells utilizing synchrotron soft X-ray imaging
利用同步加速器软 X 射线成像对肿瘤细胞中抗体药物偶联物进行药代动力学分析
- 批准号:
23H03716 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
Grant-in-Aid for Scientific Research (B)














{{item.name}}会员




